Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Urol. 2016 Mar 29;196(3):678–684. doi: 10.1016/j.juro.2016.03.144

Table 3.

Asynchronous Metastatic Sites after Diagnosis* by Metastasectomy Status

All Metastasectomy No
Metastasectomy
Metastatic Site N (%) N (%) N (%) P-Value
All Patients 24 (100%) 10 (100%) 14 (100%)
Brain 5 (21%) 5 (50%) 0 (0%) 0.01
Lung 12 (50%) 3 (30%) 9 (64%) 0.10
Mediastinum 1 (4%) 0 (0%) 1 (7%) >0.99
Liver 4 (17%) 1 (10%) 3 (21%) 0.61
Bone 2 (8%) 2 (20%) 0 (0%) 0.08
Soft Tissue 3 (13%) 2 (20%) 1 (7%) 0.55
Adrenal gland 2 (4%) 1 (3%) 1 (4%) >0.99
Retroperitoneal LN 1 (2%) 0 (0%) 1 (4%) 0.46
*

These sites are provided for the 24 patients with no distant metastases at diagnosis.